189 related articles for article (PubMed ID: 23118876)
1. Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.
Wikman H; Sielaff-Frimpong B; Kropidlowski J; Witzel I; Milde-Langosch K; Sauter G; Westphal M; Lamszus K; Pantel K
PLoS One; 2012; 7(10):e47537. PubMed ID: 23118876
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive molecular biomarker identification in breast cancer brain metastases.
Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
[TBL] [Abstract][Full Text] [Related]
3. Relevance of PTEN loss in brain metastasis formation in breast cancer patients.
Wikman H; Lamszus K; Detels N; Uslar L; Wrage M; Benner C; Hohensee I; Ylstra B; Eylmann K; Zapatka M; Sauter G; Kemming D; Glatzel M; Müller V; Westphal M; Pantel K
Breast Cancer Res; 2012 Mar; 14(2):R49. PubMed ID: 22429330
[TBL] [Abstract][Full Text] [Related]
4. Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients.
Wikman H; Westphal L; Schmid F; Pollari S; Kropidlowski J; Sielaff-Frimpong B; Glatzel M; Matschke J; Westphal M; Iljin K; Huhtala H; Terracciano L; Kallioniemi A; Sauter G; Müller V; Witzel I; Lamszus K; Kemming D; Pantel K
Oncotarget; 2014 May; 5(10):3076-87. PubMed ID: 24833255
[TBL] [Abstract][Full Text] [Related]
5. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.
Lee JY; Park K; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Hong M; Do IG; Ahn T; Lee SK; Bae SY; Kim SW; Lee JE; Nam SJ; Kim DH; Jung HH; Kim JY; Ahn JS; Im YH; Park YH
Oncotarget; 2015 Dec; 6(41):43731-42. PubMed ID: 26527317
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.
Shen Q; Sahin AA; Hess KR; Suki D; Aldape KD; Sawaya R; Ibrahim NK
Oncologist; 2015 May; 20(5):466-73. PubMed ID: 25802405
[TBL] [Abstract][Full Text] [Related]
7. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Van Swearingen AED; Siegel MB; Deal AM; Sambade MJ; Hoyle A; Hayes DN; Jo H; Little P; Dees EC; Muss H; Jolly T; Zagar TM; Patel N; Miller CR; Parker JS; Smith JK; Fisher J; Shah N; Nabell L; Nanda R; Dillon P; Abramson V; Carey LA; Anders CK
Breast Cancer Res Treat; 2018 Oct; 171(3):637-648. PubMed ID: 29938395
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
Saraf A; Grubb CS; Hwang ME; Tai CH; Wu CC; Jani A; Lapa ME; Andrews JIS; Vanderkelen S; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJC
J Neurooncol; 2017 Sep; 134(2):453-463. PubMed ID: 28674973
[TBL] [Abstract][Full Text] [Related]
9. Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis-Initiating Cells.
Yamashita D; Minata M; Ibrahim AN; Yamaguchi S; Coviello V; Bernstock JD; Harada S; Cerione RA; Tannous BA; La Motta C; Nakano I
Mol Cancer Ther; 2020 May; 19(5):1134-1147. PubMed ID: 32127468
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Profiling of Breast Cancer Brain Metastasis.
Lee JY; Park K; Lee E; Ahn T; Jung HH; Lim SH; Hong M; Do IG; Cho EY; Kim DH; Kim JY; Ahn JS; Im YH; Park YH
Sci Rep; 2016 Jun; 6():28623. PubMed ID: 27340107
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and Extracellular Vesicles as Distinctive Biomarkers of Precocious and Advanced Stages of Breast Cancer Brain Metastases Development.
Figueira I; Godinho-Pereira J; Galego S; Maia J; Haskó J; Molnár K; Malhó R; Costa-Silva B; Wilhelm I; Krizbai IA; Brito MA
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069135
[TBL] [Abstract][Full Text] [Related]
12. Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
Sambade MJ; Prince G; Deal AM; Trembath D; McKee M; Garrett A; Keith K; Ramirez J; Midkiff B; Blackwell K; Sammons S; Leone JP; Brufsky A; Morikawa A; Brogi E; Seidman A; Ewend M; Carey LA; Moschos SJ; Hamilton RL; Vincent B; Anders C
Breast Cancer Res Treat; 2019 Jul; 176(2):321-328. PubMed ID: 31016641
[TBL] [Abstract][Full Text] [Related]
13. Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays.
Brogi E; Murphy CG; Johnson ML; Conlin AK; Hsu M; Patil S; Akram M; Nehhozina T; Jhaveri KL; Hudis CA; Seidman AD
Ann Oncol; 2011 Dec; 22(12):2597-2603. PubMed ID: 21427063
[TBL] [Abstract][Full Text] [Related]
14. CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain Metastases.
Sun X; Yang N; Zhou X; Dai H; Li Q; Feng A; Xu G; Liu Y; Xu L; Zhang Z; Yang Z; Li X
Front Genet; 2022; 13():862264. PubMed ID: 35711946
[TBL] [Abstract][Full Text] [Related]
15. Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.
Hohensee I; Lamszus K; Riethdorf S; Meyer-Staeckling S; Glatzel M; Matschke J; Witzel I; Westphal M; Brandt B; Müller V; Pantel K; Wikman H
Am J Pathol; 2013 Jul; 183(1):83-95. PubMed ID: 23665199
[TBL] [Abstract][Full Text] [Related]
16. Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer.
Kulkarni S; Augoff K; Rivera L; McCue B; Khoury T; Groman A; Zhang L; Tian L; Sossey-Alaoui K
PLoS One; 2012; 7(8):e42895. PubMed ID: 22952619
[TBL] [Abstract][Full Text] [Related]
17. Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis.
Karnik P; Paris M; Williams BR; Casey G; Crowe J; Chen P
Hum Mol Genet; 1998 May; 7(5):895-903. PubMed ID: 9536095
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA
Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
[TBL] [Abstract][Full Text] [Related]
19. Clonality of circulating tumor cells in breast cancer brain metastasis patients.
Riebensahm C; Joosse SA; Mohme M; Hanssen A; Matschke J; Goy Y; Witzel I; Lamszus K; Kropidlowski J; Petersen C; Kolb-Kokocinski A; Sauer S; Borgmann K; Glatzel M; Müller V; Westphal M; Riethdorf S; Pantel K; Wikman H
Breast Cancer Res; 2019 Sep; 21(1):101. PubMed ID: 31481116
[TBL] [Abstract][Full Text] [Related]
20. Myocyte Enhancer Factor 2C as a New Player in Human Breast Cancer Brain Metastases.
Galego S; Kauppila LA; Malhó R; Pimentel J; Brito MA
Cells; 2021 Feb; 10(2):. PubMed ID: 33673112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
